Medigen Biotechnology Corp. recently discovered that certain individuals have been impersonating Medigen or its subsidiary, Yingshin Investment Co., Ltd., using LINE and other social media platforms to spread false investment information in an attempt to defraud the public. Medigen hereby solemnly clarifies that neither the company nor its subsidiary conducts any investment business via LINE or other social media platforms, and the public should not trust any unverified information. 

We remind the public that, if in doubt, they may call the National Police Agency's Anti-Fraud Hotline at 165 for verification. 
 

Medigen Biotechnology Corp.